EUR 1.0
(-1.09%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -50.45 Million EUR | -114.59% |
2022 | -50.24 Million EUR | 14.76% |
2021 | -59.09 Million EUR | -66.56% |
2020 | -35.47 Million EUR | 13.98% |
2019 | -41.23 Million EUR | 1.47% |
2018 | -41.85 Million EUR | -38.1% |
2017 | -30.3 Million EUR | -25.58% |
2016 | -24.15 Million EUR | -24.7% |
2015 | -19.39 Million EUR | 0.17% |
2014 | -19.46 Million EUR | -29.02% |
2013 | -15.02 Million EUR | 26.77% |
2012 | -20.48 Million EUR | -43.13% |
2011 | -14.33 Million EUR | -56.0% |
2010 | -9.19 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -52.4 Million EUR | 0.0% |
2023 Q2 | -32.75 Million EUR | 0.0% |
2023 Q4 | -73.56 Million EUR | 0.0% |
2023 FY | - EUR | -114.59% |
2022 FY | - EUR | 14.76% |
2022 Q2 | -24.44 Million EUR | 0.0% |
2022 Q4 | -25.93 Million EUR | 0.0% |
2021 Q4 | -34.11 Million EUR | 0.0% |
2021 FY | - EUR | -66.56% |
2021 Q2 | -24.97 Million EUR | 0.0% |
2020 Q4 | -15.1 Million EUR | 0.0% |
2020 Q2 | -20.1 Million EUR | 0.0% |
2020 FY | - EUR | 13.98% |
2019 Q2 | -23.09 Million EUR | 0.0% |
2019 Q4 | -18.14 Million EUR | 0.0% |
2019 FY | - EUR | 1.47% |
2018 FY | - EUR | -38.1% |
2018 Q2 | -18.73 Million EUR | 0.0% |
2018 Q4 | -23.12 Million EUR | 0.0% |
2017 Q2 | -14.38 Million EUR | 0.0% |
2017 FY | - EUR | -25.58% |
2017 Q4 | -15.93 Million EUR | 0.0% |
2016 Q2 | -11.11 Million EUR | 0.0% |
2016 FY | - EUR | -24.7% |
2016 Q4 | -12.96 Million EUR | 0.0% |
2015 FY | - EUR | 0.17% |
2015 Q4 | -10.4 Million EUR | 0.0% |
2015 Q2 | -8.98 Million EUR | 0.0% |
2014 FY | - EUR | -29.02% |
2014 Q2 | -10.45 Million EUR | 0.0% |
2014 Q4 | -8.99 Million EUR | 0.0% |
2013 Q1 | -3.75 Million EUR | 0.0% |
2013 Q4 | -9.95 Million EUR | -164.81% |
2013 FY | - EUR | 26.77% |
2013 Q3 | -3.75 Million EUR | 28.33% |
2013 Q2 | -5.24 Million EUR | -39.53% |
2012 Q4 | -3.75 Million EUR | 26.46% |
2012 Q1 | -5.11 Million EUR | 0.0% |
2012 FY | - EUR | -43.13% |
2012 Q3 | -5.11 Million EUR | 0.0% |
2012 Q2 | -5.11 Million EUR | 0.0% |
2011 Q1 | -3.56 Million EUR | 0.0% |
2011 Q3 | -3.56 Million EUR | 0.0% |
2011 Q4 | -5.11 Million EUR | -43.45% |
2011 FY | - EUR | -56.0% |
2011 Q2 | -3.56 Million EUR | 0.0% |
2010 FY | - EUR | 0.0% |
2010 Q4 | -3.56 Million EUR | -55.32% |
2010 Q1 | -2.29 Million EUR | 0.0% |
2010 Q3 | -2.29 Million EUR | 0.0% |
2010 Q2 | -2.29 Million EUR | 0.0% |
2009 Q4 | -2.29 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Affluent Medical SA | -13.34 Million EUR | -278.116% |
Bluelinea Société Anonyme | -323.98 EUR | -15572466.208% |
Diagnostic Medical Systems S.A. | -7.05 Million EUR | -614.921% |
Euromedis Groupe | -4.43 Million EUR | -1037.539% |
Eurobio Scientific Société anonyme | 18.98 Million EUR | 365.733% |
Ikonisys S.A. | -2.34 Million EUR | -2049.156% |
Implanet S.A. | -5.07 Million EUR | -893.736% |
Median Technologies SA | -19.58 Million EUR | -157.605% |
SpineGuard SA | -3.49 Million EUR | -1342.797% |
Theraclion SA | -4.48 Million EUR | -1024.344% |
Euroapi S.A. | -155.39 Million EUR | 67.534% |
Guerbet SA | 98.83 Million EUR | 151.045% |
Ion Beam Applications SA | 12.53 Million EUR | 502.65% |
Koninklijke Philips N.V. | 1.04 Billion EUR | 104.846% |
Sequana Medical NV | -29.13 Million EUR | -73.155% |